BioSpace News Archive

Zoetis Inc. (NYSE:ZTS) will participate in the 18th Annual Morgan Stanley Healthcare Conference on Wednesday, Sept. 16, 2020. Kristin Peck, Chief Executive Officer, and Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. They are scheduled to present virtually at 8:00 a.m. ET. Investors and other interested parties will be able to

CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced its continued expansion into condition specific dietary supplements with the launch of CV™ Defense, the second of several products to be launched under its new Immunity product line, following the launch of CV™ Acute in August.

Aileron Therapeutics (NASDAQ:ALRN) today announced that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, will give a corporate presentation at the upcoming H.C. Wainwright Virtual Global Investment Conference, including an update on the company’s efforts to advance chemoprotection for patients with p53-mutated cancers regardless of cancer type or chemotherapeutic drug. The presentation is scheduled for September 14, 2020